(Q37820692)

23 August 2017

1 reference

title

Review: An update on inflammatory and autoimmune myopathies (English)

1 reference

23 August 2017

0 references

M C Dalakas

1

1 reference

23 August 2017

publication date

1 April 2011

1 reference

Neuropathology and Applied Neurobiology

23 August 2017

published in

1 reference

23 August 2017

volume

37

1 reference

23 August 2017

issue

3

1 reference

23 August 2017

page(s)

226-242

1 reference

Polymyositis, dermatomyositis and inclusion-body myositis

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

Polymyositis and dermatomyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

Idiopathic inflammatory myopathies: epidemiology, classification, and diagnostic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

Inflammatory muscle diseases: a critical review on pathogenesis and therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

Pathomechanisms of inflammatory myopathies: recent advances and implications for diagnosis and therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

Sporadic inclusion body myositis--diagnosis, pathogenesis and therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

Inclusion body myositis: new concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

Inclusion body myositis: current pathogenetic concepts and diagnostic and therapeutic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

HLA allele distribution distinguishes sporadic inclusion body myositis from hereditary inclusion body myopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

An inflammatory, familial, inclusion body myositis with autoimmune features and a phenotype identical to sporadic inclusion body myositis. Studies in three families

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

Inclusion body myositis and myopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

Enhanced detection of congo-red-positive amyloid deposits in muscle fibers of inclusion body myositis and brain of Alzheimer's disease using fluorescence technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

Inclusion body myositis: a degenerative muscle disease associated with intra-muscle fiber multi-protein aggregates, proteasome inhibition, endoplasmic reticulum stress and decreased lysosomal degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

p62/SQSTM1 is overexpressed and prominently accumulated in inclusions of sporadic inclusion-body myositis muscle fibers, and can help differentiating it from polymyositis and dermatomyositis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

Myofibrillar myopathy: clinical, morphological and genetic studies in 63 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

Proteasomal expression, induction of immunoproteasome subunits, and local MHC class I presentation in myofibrillar myopathy and inclusion body myositis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

Involvement of clusterin and the aggresome in abnormal protein deposits in myofibrillar myopathies and inclusion body myositis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

Rimmed vacuoles with beta-amyloid and ubiquitinated filamentous deposits in the muscles of patients with long-standing denervation (postpoliomyelitis muscular atrophy): similarities with inclusion body myositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

Nature of "Tau" immunoreactivity in normal myonuclei and inclusion body myositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

Sarcoplasmic redistribution of nuclear TDP-43 in inclusion body myositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

Tragedy in a heartbeat: malfunctioning desmin causes skeletal and cardiac muscle disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

The UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase gene is mutated in recessive hereditary inclusion body myopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

Mechanisms of disease: signaling pathways and immunobiology of inflammatory myopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

Expression of immunoreactive major histocompatibility complex products in human skeletal muscles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes, and T cell-mediated cytotoxicity in myopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

CAPN3 mutations in patients with idiopathic eosinophilic myositis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

Immunopathogenesis of inflammatory myopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

Differential expression of chemokines in inflammatory myopathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

Cytokines, chemokines, and cell adhesion molecules in inflammatory myopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

Expression of the dermatomyositis autoantigen Mi-2 in regenerating muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

Cathepsins are upregulated by IFN-gamma/STAT1 in human muscle culture: a possible active factor in dermatomyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

Type I interferon-inducible gene expression in blood is present and reflects disease activity in dermatomyositis and polymyositis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

Gene expression profiling in DQA1*0501+ children with untreated dermatomyositis: a novel model of pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

Gene expression profile in the muscles of patients with inflammatory myopathies: effect of therapy with IVIg and biological validation of clinically relevant genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

Viruses in idiopathic inflammatory myopathies: absence of candidate viral genomes in muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

Absence of persistent infection with enteroviruses in muscles of patients with inflammatory myopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

The immunobiology of muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

Immunobiology of muscle: advances in understanding an immunological microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

Muscle fibres and cultured muscle cells express the B7.1/2-related inducible co-stimulatory molecule, ICOSL: implications for the pathogenesis of inflammatory myopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

Upregulated inducible co-stimulator (ICOS) and ICOS-ligand in inclusion body myositis muscle: significance for CD8+ T cell cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

Muscle inflammation and MHC class I up-regulation in muscular dystrophy with lack of dysferlin: an immunopathological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

Differential expression of perforin in muscle-infiltrating T cells in polymyositis and dermatomyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

Coculture with autologous myotubes of cytotoxic T cells isolated from muscle in inflammatory myopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

Cytotoxic mechanisms in inflammatory myopathies. Co-expression of Fas and protective Bcl-2 in muscle fibres and inflammatory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

Immunolocalization of tumor necrosis factor-alpha and its receptors in inflammatory myopathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

T cell receptor repertoire in polymyositis: clonal expansion of autoaggressive CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

Analysis of T cell receptor repertoire of muscle-infiltrating T lymphocytes in polymyositis. Restricted V alpha/beta rearrangements may indicate antigen-driven selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

Clonal biases of peripheral CD8 T cell repertoire directly reflect local inflammation in polymyositis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

Clonal tracking of autoaggressive T cells in polymyositis by combining laser microdissection, single-cell PCR, and CDR3-spectratype analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

Autoaggressive myocytotoxic T lymphocytes expressing an unusual gamma/delta T cell receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

Expression of the costimulatory molecule BB-1, the ligands CTLA-4 and CD28, and their mRNA in inflammatory myopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

Interrelation of inflammation and APP in sIBM: IL-1 beta induces accumulation of beta-amyloid in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

Myeloid dendritic cells in inclusion-body myositis and polymyositis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

A local antigen-driven humoral response is present in the inflammatory myopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

Inflammatory, immune, and viral aspects of inclusion-body myositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

Inclusion body myositis: the mumps virus hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

Neuromuscular diseases associated with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

HTLV-1 and polymyositis in Jamaica

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

Inclusion body myositis in HIV-1 and HTLV-1 infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

Molecular analysis of T cell clonotypes in muscle-infiltrating lymphocytes from patients with human T lymphotropic virus type 1 polymyositis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

Direct evidence for a chronic CD8+-T-cell-mediated immune reaction to tax within the muscle of a human T-cell leukemia/lymphoma virus type 1-infected patient with sporadic inclusion body myositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

Inclusion body myositis with human immunodeficiency virus infection: four cases with clonal expansion of viral-specific T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

Proteasome inhibition and aggresome formation in sporadic inclusion-body myositis and in amyloid-beta precursor protein-overexpressing cultured human muscle fibers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

Presence of BACE1 and BACE2 in muscle fibres of patients with sporadic inclusion-body myositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

Beta-amyloid is a substrate of autophagy in sporadic inclusion body myositis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

Localization and MHC class II presentation of antigens targeted for macroautophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

Inflammation induces tau pathology in inclusion body myositis model via glycogen synthase kinase-3beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

AlphaB-crystallin immunolocalization yields new insights into inclusion body myositis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

Proinflammatory cell stress in sporadic inclusion body myositis muscle: overexpression of alphaB-crystallin is associated with amyloid precursor protein and accumulation of beta-amyloid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

Myopathy with antibodies to the signal recognition particle: clinical and pathological features

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

Toxic and drug-induced myopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

Therapeutic targets in patients with inflammatory myopathies: present approaches and a look to the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

Immunotherapy of myositis: issues, concerns and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

Inflammatory myopathies: clinical, diagnostic and therapeutic aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

Sporadic inclusion body myositis: a continuing puzzle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

Treatment of inclusion-body myositis with IVIg: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

Dermatomyositis with inclusion body myositis pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

Effect of Alemtuzumab (CAMPATH 1-H) in patients with inclusion-body myositis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

Clinical applications of intravenous immunoglobulins in neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

Long-term persistence of clonally expanded T cells in patients with polymyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01153.X

10.1111/J.1365-2990.2010.01153.X

21 January 2018

Identifiers

DOI

1 reference

23 August 2017

1 reference